Mechanisms of decreased expression of transforming growth factor-beta receptor type I at late stages of HPV16-mediated transformation
Authors:
- 2 April 2009
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 282 (2) , 177-186
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- TGF‐β signaling: A tale of two responsesJournal of Cellular Biochemistry, 2007
- Transforming growth factor-β in cancer and metastasisCancer and Metastasis Reviews, 2006
- The logic of TGFβ signalingFEBS Letters, 2006
- TGF‐β control of cell proliferationJournal of Cellular Biochemistry, 2005
- Restoration of expression of transforming growth factor-β Type II receptor in murine renal cell carcinoma (renca) cells by 5-Aza-2′-deoxycytidineLife Sciences, 2005
- Identification of genetic alterations in the TGFβ type II receptor gene promoterMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2001
- 5-AzaC Treatment Enhances Expression of Transforming Growth Factor-β Receptors through Down-regulation of Sp3Journal of Biological Chemistry, 2001
- Induction of Transforming Growth Factor-β Receptor Type II Expression in Estrogen Receptor-positive Breast Cancer Cells through SP1 Activation by 5-Aza-2′-deoxycytidineJournal of Biological Chemistry, 1998
- TGF‐β receptor‐mediated signalling through Smad2, Smad3 and Smad4The EMBO Journal, 1997
- Structure and expression of the promoter for the R4/ALK5 human type I transforming growth factor-β receptor: regulation by TGF-βBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1996